Specificity of DNA ADP-Ribosylation Reversal by NADARs.

Toxins (Basel)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

Published: April 2024

AI Article Synopsis

  • Recent research shows that DNA and RNA are key targets for a modification process called ADP-ribosylation, with specific enzymes known as NADARs that can reverse this modification and function as protectors against toxins.
  • While NADAR enzymes are found in a variety of organisms, their precise functions and impacts are not fully understood, prompting studies to analyze their activity and specificity in protecting cells from harmful modifications.
  • Notably, a newly identified enzyme from myxobacteria has been discovered to act as an antitoxin against a specific toxin, revealing new insights into toxin-antitoxin systems and highlighting the potential of NADARs as targets for developing precise antimicrobial treatments.

Article Abstract

Recent discoveries establish DNA and RNA as bona fide substrates for ADP-ribosylation. NADAR ("NAD- and ADP-ribose"-associated) enzymes reverse guanine ADP-ribosylation and serve as antitoxins in the DarT-NADAR operon. Although NADARs are widespread across prokaryotes, eukaryotes, and viruses, their specificity and broader physiological roles remain poorly understood. Using phylogenetic and biochemical analyses, we further explore de-ADP-ribosylation activity and antitoxin functions of NADAR domains. We demonstrate that different subfamilies of NADAR proteins from representative strains and an -infecting phage retain biochemical activity while displaying specificity in providing protection from toxic guanine ADP-ribosylation in cells. Furthermore, we identify a myxobacterial enzyme within the YbiA subfamily that functions as an antitoxin for its associated DarT-unrelated ART toxin, which we termed YarT, thus presenting a hitherto uncharacterised ART-YbiA toxin-antitoxin pair. Our studies contribute to the burgeoning field of DNA ADP-ribosylation, supporting its physiological relevance within and beyond bacterial toxin-antitoxin systems. Notably, the specificity and confinement of NADARs to non-mammals infer their potential as highly specific targets for antimicrobial drugs with minimal off-target effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11125620PMC
http://dx.doi.org/10.3390/toxins16050208DOI Listing

Publication Analysis

Top Keywords

dna adp-ribosylation
8
guanine adp-ribosylation
8
adp-ribosylation
5
specificity
4
specificity dna
4
adp-ribosylation reversal
4
reversal nadars
4
nadars discoveries
4
discoveries establish
4
establish dna
4

Similar Publications

Mono(ADP-ribosyl)ation (MARylation) is emerging as a critical regulator of ribosome function and translation. Herein, we demonstrate that RACK1, an integral component of the ribosome, is MARylated by the mono(ADP-ribosyl) transferase (MART) PARP14 in ovarian cancer cells. MARylation of RACK1 is required for stress granule formation and promotes the colocalization of RACK1 in stress granules with G3BP1, eIF3η, and 40S ribosomal proteins.

View Article and Find Full Text PDF

PARylation facilitates the DNA damage repair of Phytophthora sojae in response to host ROS stress.

Int J Biol Macromol

December 2024

Department of Plant Pathology, College of Plant Protection, China Agricultural University, Beijing, China; State Key Laboratory of Crop Stress Biology for Arid Areas, College of Plant Protection, Northwest A&F University, Yangling, China. Electronic address:

Host plants and various fungicides combat plant pathogens by triggering the release of excessive ROS, leading to DNA damage and subsequent cell death. The mechanisms by which the Phytophthora sojae mitigates ROS stress induced by plant immune responses and fungicides are not well understood. This study investigates the role of PsPARP1A-mediated poly (ADP-ribosylation) (PARylation) in ROS-induced DNA damage responses (DDR).

View Article and Find Full Text PDF

NSC-3852 synergistically enhances the cytotoxicity of olaparib in oral squamous cell carcinoma.

Biochem Biophys Res Commun

January 2025

Department of Pharmacology, Faculty of Dentistry, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata, Osaka 573-1121, Japan. Electronic address:

The PARP inhibitor olaparib is an anti-cancer agent based on synthetic lethality that targets poly (ADP-ribose) polymerases. It is used as a therapeutic agent for breast, ovarian, pancreatic, and prostate cancers carrying BRCA1/2 mutations that cause deficiency in homologous recombination. In recent years, acquired resistance to PARP inhibitors has become a clinical problem in PARP inhibitor-treated patients.

View Article and Find Full Text PDF

RUNX3 is a master developmental transcriptional factor that has been implicated as a tumor suppressor in many cancers. However, the exact role of RUNX3 in cancer pathogenesis remains to be completely elucidated. Recently, it has emerged that RUNX3 is involved in the DNA damage response.

View Article and Find Full Text PDF

Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader.

Cell Death Dis

December 2024

Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

Poly (ADP-ribose) polymerase 1 (PARP1) catalyzes poly (ADP) ribosylation reaction, one of the essential post-translational modifications of proteins in eukaryotic cells. Given that PARP1 inhibition can lead to synthetic lethality in cells with compromised homologous recombination, this enzyme has been identified as a potent target for anti-cancer therapeutics. However, the clinical application of existing PARP1 inhibitors is restrained by side effects associated with DNA trapping and off-target effects, highlighting the need for improved therapeutic strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!